It belongs to a class of drugs known as GLP-1 receptor agonists
If you're not familiar with the term GLP-1 medications, there's a decent chance you've heard them mentioned by their brand names
Ozempic label, DailyMed Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity, JAMA Network (2022) Prior authorization and pre-claim review initiatives, Centers for Medicare & Medicaid Services Medicaid coverage of and spending on GLP-1s, KFF (2026) State profiles, Centers for Medicare & Medicaid Services State Medicaid pharmacy copay requirements, KFF Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Clinical trials have shown promising results, with many participants experiencing significant weight loss and improvements in metabolic markers
To get the best results, you need to be steady and keep using it as told
Wegovy is a 'name-brand' form of semaglutide, a type of medication called a glucagon-like peptide 1 receptor agonist, better known as a GLP-1. Semaglutide the active ingredient in Wegovy works by mimicking the GLP-1 hormones that are naturally secreted by the intestine after a meal
